Joe Abdo, PhD, is a molecular oncology scientist with 18+ years of experience in cancer diagnostics, translational research, and biotech business development. He has held leadership roles in public and private life science companies, focusing on early cancer detection, immunotherapy response prediction, and clinical utility studies. He has authored 50+ peer-reviewed publications, which have been cited over 1000+ times in the fields of molecular oncology, proteomics, and precision medicine (Source: GoogleScholar). As Vice President of Clinical Diagnostics at Oxford BioDynamics, he leads clinical strategy and real-world evidence programs for 3D genomic testing platforms. A brain cancer survivor, Joe channels his personal experience into advancing patient-centered innovations. He also lectures at Georgetown University Medical Center, teaching ‘Entrepreneurial Biotechnology’ and ‘Core Methods in Biotechnology,’ and has received Georgetown’s Outstanding Mentor Award (2022 & 2025) and Creighton’s Academic Achievement Award (2018).